As an intern, in 1972, what I feared most was caring for an acute myocardial infarction (MI). Prior to the coronary care unit (CCU), developed in Kansas in the 1960’s, the mortality of an acute MI was 30% and subsequently dropped to 15% because of effective treatment of arrhythmias. Otherwise treatment was oxygen, morphine, listening to the patient, and providing support for the family.
Article By:
I would like to welcome everyone to the Potpourri Edition of LipidSpin – brought to you this year as a joint effort between the Northeast and Southeast Lipid Associations. This is the first LipidSpin edition that I have the good fortune of introducing to you as President of the National Lipid Association.
Article By:
View the September 2020 SWLA E-Newsletter by clicking here.
Regeneron Pharmaceuticals, Inc. today announced that the New England Journal of Medicine (NEJM) published positive results from the Phase 3 trial of evinacumab in 65 patients with homozygous familial hypercholesterolemia (HoFH).
The NLA is excited to share that we will host our first-ever virtual Scientific Sessions! Due to current travel restrictions and gathering limitations in the city of Chicago, the NLA has made the difficult decision to rescope our 2020 Scientific Sessions into a fully virtual conference held live on Thursday, December 10 – Saturday, December 12, 2020.
There will be a reduced meeting registration for the virtual conference at a discounted rate of only $299. Registration for the virtual sessions will open at the end of August.
View the August 2020 NELA E-Newsletter by clicking here.
August President's Message
Dr. Joseph Saseen takes a look ahead at what is to come for the NLA, including LipidPALOOZA in September!
The National Lipid Association is excited to announce a month-long extravaganza of virtual education, LipidPALOOZA, launching this September to celebrate National Cholesterol Education Month. There will be a variety of activities spread throughout the entire month and best of all, they will be offered at no charge.
Each Friday in September, LipidPALOOZA will feature a half-day of sensational content comprised of:
View the July 2020 SELA E-Newsletter by clicking here.
Testosterone is a predominantly male hormone responsible for virilization of the external male genitalia during embryonic development, promotion of somatic growth, and secondary sexual characteristics in puberty, normal sexual function and libido in both males and females, and promotion of bone formation, bone health and maintenance of bone and muscle mass in adults.(1,2) It circulates in females at approximately 13-14% of the level observed in males.(3) Testosterone levels in females d


.png)










